Inventor · disambiguated record
Tan A. Ince
Also filed as: INCE TAN · INCE TAN A
9 granted patents·11 pending applications·23 citations·filing 2005–2023
82Inventor score
Top patents by PatentIndex Score
20 records- 0191US8252591B2Hormone responsive tissue culture system and uses thereofINCE TAN A·Filed 2005·Granted Aug 28, 2012·17 cites·31 claims
- 0285US8936939B2Hormone responsive tissue culture system and uses thereofINCE TAN A·Filed 2012·Granted Jan 20, 2015·4 cites·20 claims
- 0379US10465166B2Cell culture mediaUNIV MIAMI·Filed 2017·Granted Nov 5, 2019·1 cites·8 claims
- 0474US9777256B2Cell culture mediaUNIV MIAMI·Filed 2014·Granted Oct 3, 2017·1 cites·16 claims
- 0570US11332712B2Cell culture media and method for culturing breast cancer cellsUNIV MIAMI·Filed 2019·Granted May 17, 2022·0 cites·8 claims
- 0665US2015259644A1Hormone responsive tissue culture system and uses thereofINCE TAN A·Filed 2014·Application pending·0 cites
- 0763US2024226074A1Cell-of-origin targeted drug repurposing for triple-negative and inflammatory breast carcinoma with hdac and hsp90 inhibitors combined with niclosamideINCE TAN A·Filed 2023·Application pending·0 cites
- 0863US2018155687A1Hormone responsive tissue culture system and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2017·Application pending·0 cites
- 0962US2025305055A1Prognostic/predictive breast cancer signatureUNIV CORNELL·Filed 2022·Application pending·0 cites
- 1061US2019071634A1Compositions and methods for culturing cells from normal human tubo-ovarian epithelium and human tubo-ovarian tumorsWHITEHEAD INST BIOMEDICAL RES·Filed 2018·Application pending·0 cites
- 1159US2011244502A1Hormone responsive tissue culture system and uses thereofWHITEHEAD BIOMEDICAL INST·Filed 2008·Application pending·0 cites
- 1258US11530385B2Hormone responsive tissue culture system and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2017·Granted Dec 20, 2022·0 cites·6 claims
- 1354US2016319239A1Compositions and methods for culturing cells from normal human tubo-ovarian epithelium and human tubo-ovarian tumorsWHITEHEAD INST BIOMEDICAL RES·Filed 2016·Application pending·0 cites
- 1453US2014170693A1Compositions and methods for culturing cells from normal human tubo-ovarian epithelium and human tubo-ovarian tumorsINCE TAN A·Filed 2012·Application pending·0 cites
- 1550US2022016135A1Treating breast cancer with hormone receptor modulatorsUNIV MIAMI·Filed 2020·Application pending·0 cites
- 1646US2016102365A1Assays, methods and kits for analyzing sensitivity and resistance to anti-cancer drugs, predicting a cancer patient's prognosis, and personalized treatment strategiesUNIV MIAMI·Filed 2014·Application pending·0 cites
- 1746US2016146819A1Classification system, methods and kit for classifying, predicting and treating breast cancerUNIV MIAMI·Filed 2014·Application pending·0 cites
- 1845US9683217B2In vitro culture conditions for T-cell acute lymphoblastic leukemia/lymphomaTHE UNIV OF MIAMI·Filed 2013·Granted Jun 20, 2017·0 cites·37 claims
- 1945US8912156B1Markers for and methods of targeting tumor stem cellsINCE TAN A·Filed 2012·Granted Dec 16, 2014·0 cites·18 claims
- 2037US9696313B2HSF1 as a marker in tumor prognosis and treatmentWHITEHEAD INST FOR BIO-MEDICAL RES·Filed 2012·Granted Jul 4, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Tan A. Ince files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →